当前位置：首页 JCRQ1 期刊介绍(非官网)

Cell Reports Medicine

SCI SCIE

国际简称：Cell Rep Med 参考译名：细胞医学报道

中科院分区
1区
CiteScore分区
Q1
JCR分区
Q1

基本信息：: ISSN：2666-3791; E-ISSN：2666-3791; 是否OA：开放; 是否预警：否; TOP期刊：是

出版信息：: 出版地区：United States; 出版商：Elsevier; 出版语言：English; 出版周期：Monthly; 出版年份：2020; 研究方向：Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)

评价信息：: 影响因子：14; CiteScore指数：15.9; SJR指数：4.932; SNIP指数：2.319

发文数据：: Gold OA文章占比：99.73%; 研究类文章占比：93.29%; 年发文量：417; 自引率：0.0139...; 开源占比：0.8876; 出版撤稿占比：; 出版国人文章占比：0; OA被引用占比：

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Cell Reports Medicine期刊介绍

Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.

The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.

Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.

The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.

期刊简介Cell Reports Medicine期刊介绍

《Cell Reports Medicine》自2020出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCI、SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：17 Weeks
国际TOP期刊
医学
细胞生物学
SCI
SCIE
中科院1区
非预警

Cite Score数据（2026年6月最新版）Cell Reports Medicine Cite Score数据

CiteScore：15.9
SJR：4.932
SNIP：2.319

学科类别	分区	排名	百分位
大类：Medicine 小类：General Medicine	Q1	20 / 669	97%
大类：Medicine 小类：General Biochemistry, Genetics and Molecular Biology	Q1	14 / 223	93%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Cell Reports Medicine 中科院分区

《新锐期刊分区表》（2026年3月发布） 综述期刊：否 Top期刊：是

大类学科	分区	小类学科	分区
医学	1区	CELL BIOLOGY 细胞生物学 MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验	1区 1区

期刊分区表（2025年3月升级版） 综述期刊：否 Top期刊：是

大类学科	分区	小类学科	分区
医学	1区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验 CELL BIOLOGY 细胞生物学	1区 2区

期刊分区表（2023年12月升级版） 综述期刊：否 Top期刊：是

大类学科	分区	小类学科	分区
医学	1区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验 CELL BIOLOGY 细胞生物学	1区 2区

期刊分区表（2022年12月升级版） 综述期刊：否 Top期刊：是

大类学科	分区	小类学科	分区
医学	1区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验 CELL BIOLOGY 细胞生物学	1区 2区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Cell Reports Medicine JCR分区

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CELL BIOLOGY	SCIE	Q1	21 / 207	90.1
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q1	12 / 191	94
学科：CELL BIOLOGY	SCIE	Q1	15 / 207	93
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q1	10 / 191	95.03

2023-2024年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CELL BIOLOGY	SCIE	Q1	22 / 205	89.5
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q1	10 / 189	95
学科：CELL BIOLOGY	SCIE	Q1	14 / 205	93.41
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q1	8 / 189	96.03

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

本刊中国学者近年发表论文

1、Blood-brain barrier-penetrative lipid nanoparticles enable systemic delivery of TRIM11 mRNA to disaggregate Tau in Alzheimer's disease model
Author: Zou, Yan; Sang, Yujing; Zheng, Meng; Shi, Bingyang

Journal: CELL REPORTS MEDICINE. 2026; Vol. 7, Issue 3, pp. -. DOI: 10.1016/j.xcrm.2026.102685
2、Lipid-lowering and glucose-lowering drug targets differentially modulate antipsychotic treatment efficacy in schizophreni
Author: Zhu, Yunqing; Yuan, Rui; Lu, Zhe; Zhang, Yuyanan; Kang, Zhewei; Feng, Xiaoyang; Zhao, Guorui; Sun, Junyuan; Guo, Jing; Yu, Tong; Yang, Yang; Sun, Yaoyao; Yue, Weihua

Journal: CELL REPORTS MEDICINE. 2026; Vol. 7, Issue 3, pp. -. DOI: 10.1016/j.xcrm.2026.102653
3、Engineering lipid nanoparticle-stabilized emulsions for spatiotemporal mRNA delivery and enhanced T cell immunit
Author: Zhou, Yan; Gao, Weixiang; Huang, Xiaonan; Yan, Yumeng; Wu, Sihua; Shan, Xiangfei; Chen, Shaoyi; Qiu, Mantang; Ma, Guanghui; Xia, Yufei

Journal: CELL REPORTS MEDICINE. 2026; Vol. 7, Issue 3, pp. -. DOI: 10.1016/j.xcrm.2026.102667
4、Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cance
Author: Zhang, Tingting; Cui, Wangpeng; Tang, Haitao; Shen, Cenkai; Zhang, Yan; Sun, Yaoting; Zhou, Yan; Shen, Chentian; Xu, Huajun; Wang, Chenyi; Ding, Wenyang; Zheng, Fuxing; Xu, Tiansheng; Liu, Chuqiao; Du, Yuxin; Liu, Zhiyan; Wang, Yulong; Huang, Naisi; Mao, Xiaoqi; Ji, Dongmei; Sun, Xing; Ji, Qinghai; Wei, Wenjun; Wang, Yu; Shi, Xiao

Journal: CELL REPORTS MEDICINE. 2026; Vol. 7, Issue 3, pp. -. DOI: 10.1016/j.xcrm.2026.102661
5、Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cance
Author: Zhang, Shenghua; Cui, Ming; Huang, Xinmei; Feng, Xiaoyao; Xiao, Ruiling; Liu, Qijia; Bai, Jialu; Han, Xianlin; Liu, Xiaoding; Xu, Weiyan; Huang, Jing; Liao, Quan; Zhao, Yupei; Qiu, Xiaoyan

Journal: CELL REPORTS MEDICINE. 2026; Vol. 7, Issue 3, pp. -. DOI: 10.1016/j.xcrm.2026.102660
6、Targeted AAV6 gene therapy restores corneal endothelial function in three hereditary corneal dystrophie
Author: Zhang, Bi Ning; Qi, Benxiang; Chen, Shijiu; Su, Jing; Li, Guoyun; Wang, Xinping; Ren, Zhongmei; Zhang, Hengrui; Cheng, Jun; Qu, Jingyu; Yang, Yang; Zhou, Qingjun; Cong, Lin; Xie, Lixin

Journal: CELL REPORTS MEDICINE. 2026; Vol. 7, Issue 3, pp. -. DOI: 10.1016/j.xcrm.2026.102649
7、pH-regulating Lipiodol Pickering emulsions enhance transarterial embolization therapy via inducing ferroptosis and activating antitumor immunit
Author: Yang, Weihao; Wang, Chunjie; Yu, Chao; Jiang, Nan; Yu, Bin; Ni, Yicheng; Ni, Caifang; Feng, Liangzhu; Zhang, Lei

Journal: CELL REPORTS MEDICINE. 2026; Vol. 7, Issue 3, pp. -. DOI: 10.1016/j.xcrm.2026.102662
8、Comprehensive single-cell metabolic profiling identifies targets to sensitize triple-negative breast cancer to chemo-immunotherap
Author: Xu, Ying; Liu, Xin-Yi; Zhang, Hang; Chen, Li; Wang, Han; Shao, Zhi-Ming; Xiao, Yi; Jiang, Yi-Zhou

Journal: CELL REPORTS MEDICINE. 2026; Vol. 7, Issue 3, pp. -. DOI: 10.1016/j.xcrm.2026.102659